Merck & Co. said Friday that its experimental COVID-19 pill reduced hospitalizations and deaths by half in people recently infected with the coronavirus and that it would soon ask health officials in the U.S. and around the world to authorize its use.
If cleared, Merck's drug would be the first pill shown to treat COVID-19, a potentially major advance in efforts to fight the pandemic. All COVID-19 therapies now authorized in the U.S. require an IV or injection.
Read more at:
Merck says experimental drug molnupiravir cuts worst effects of COVID-19 | CBC News
Showing posts with label Good Results. Show all posts
Showing posts with label Good Results. Show all posts
Tuesday, October 5, 2021
Wednesday, June 9, 2021
Vaccines: COVID-19 Vaccines Are Better Than We Ever Expected
Amid a global tragedy, the striking effectiveness of vaccines against the coronavirus stands out as one of the pandemic’s few good-news stories for humanity.
And the vaccines are the success story that, so far, has kept on going. Vaccinations are proving to be just as effective in the real world as they were in clinical trials, while remaining highly protective against the more contagious variants spreading worldwide. And two recent studies found that immunity to the virus could last for years.
Read more at: COVID-19 Vaccines Are Better Than We Ever Expected
And the vaccines are the success story that, so far, has kept on going. Vaccinations are proving to be just as effective in the real world as they were in clinical trials, while remaining highly protective against the more contagious variants spreading worldwide. And two recent studies found that immunity to the virus could last for years.
Read more at: COVID-19 Vaccines Are Better Than We Ever Expected
Subscribe to:
Posts (Atom)